Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial

IMPORTANCE: Whether culture expanded mesenchymal stem cells or whole bone marrow mononuclear cells are safe and effective in chronic ischemic cardiomyopathy (ICM) remains controversial. OBJECTIVE: To demonstrate the safety of transendocardial stem cell injection with autologous mesenchymal stem cell...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Heldman, Alan W., DiFede, Darcy L., Fishman, Joel E, Zambrano, Juan P., Trachtenberg, Barry H., Karantalis, Vasileios, Mushtaq, Muzammil, Williams, Adam R., Suncion, Viky Y., McNiece, Ian K., Ghersin, Eduard, Soto, Victor, Lopera, Gustavo, Miki, Roberto, Willens, Howard, Hendel, Robert, Mitrani, Raul, Pattany, Pradip, Feigenbaum, Gary, Oskouei, Behzad, Byrnes, John, Lowery, Maureen H., Sierra, Julio, Pujol, Mariesty V, Delgado, Cindy, Gonzalez, Phillip J., Rodriguez, Jose E., Bagno, Luiza Lima, Rouy, Didier, Altman, Peter, Foo, Cheryl Wong Po, da Silva, Jose, Anderson, Erica, Schwarz, Richard, Mendizabal, Adam, Hare, Joshua M.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2014
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111133/
https://ncbi.nlm.nih.gov/pubmed/24247587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2013.282909
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים